Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on c h activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110590774B details a green photocatalytic route for C3-trifluoromethylation, offering mild conditions and high purity for pharmaceutical intermediates.
Novel Pd-catalyzed cyclization for ferrocene piperidones. High yield, air-stable process reduces manufacturing costs for pharmaceutical intermediates.
Patent CN111039867A reveals a room-temperature photochemical route for isoquinoline derivatives, offering significant cost reduction and greener supply chain solutions for pharmaceutical intermediates.
Patent CN113912550A details a green synthesis of 2,4,5-trichloropyrimidine using sodium hypochlorite, offering cost reduction in agrochemical intermediate manufacturing.
Patent CN120682268A reveals Pd-catalyzed synthesis of silicon heterocycles. Offers mild conditions and scalable routes for reliable pharma intermediate supply chains.
Novel Pd-catalyzed C-H activation route for catechol derivatives. Mild conditions, scalable one-pot process, significant cost reduction potential for pharmaceutical manufacturing.
Patent CN108164397B reveals a novel Pd-catalyzed C-H acetoxylation route for catechol derivatives, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN117466799A reveals efficient one-pot synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing and high-purity N-substituted phthalimide.
Patent CN114213384B reveals a ruthenium-catalyzed route for isocoumarins. This method offers significant supply chain stability and cost reduction advantages.
Patent CN106831765B reveals Rh-catalyzed nitrilation for high-purity pharmaceutical intermediate manufacturing with enhanced supply chain reliability and cost efficiency.
Patent CN111763222B reveals a green route for edoxaban free base. Eliminate Pd catalysts and genotoxic impurities for cost-effective API manufacturing.
Patent CN115894366A details a Rh-catalyzed C-H activation route for novel amino acids, offering high yields and simplified purification for reliable pharmaceutical intermediate supply chains.
Patent CN112209859B reveals a safer CDI-based route for Iguratimod intermediates, offering high purity and reduced operational hazards for API manufacturing.
Patent CN107235900B reveals a mild, metal-free radical route for 6-benzylphenanthridine compounds, offering significant cost reduction and safety advantages for API manufacturing.
Patent CN101519428B details a low-cost, high-purity synthesis of L-alanyl-L-glutamine using mixed anhydride activation, offering significant supply chain advantages.
Patent CN113150031A discloses a novel oxaspiro chiral phosphoric acid enabling >97% ee in asymmetric synthesis. Reliable supplier for high-purity pharmaceutical intermediates.
Discover the novel Ruthenium-catalyzed synthesis of 3-cyanoquinoline derivatives from patent CN113620875B. Offers cost reduction in API manufacturing and scalable green chemistry solutions.
Patent CN106336367B offers safe ruthenium-catalyzed route. Enhances supply chain reliability and reduces safety costs for fine chemical intermediate manufacturing.
Patent CN117658864B details a high-yield route for sacubitril intermediates offering supply chain stability and cost reduction for pharmaceutical manufacturing.
Novel Rh-catalyzed one-step synthesis for dihydrocinnamates. Reduces steps, avoids hydrogenation. Reliable supplier for pharma and fragrance intermediates.